AMY BUCK: Open Payments
NPI 1053587402 · O FALLON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,346 in 213 payments from 16 companies in 2025. Trend: 2023 $825 · 2024 $1,227 · 2025 $22,346
Honoraria: $17,064Food & beverage: $3,460Travel & lodging: $1,822
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 43 | $19,955 |
| Novo Nordisk Inc | 37 | $486 |
| AstraZeneca Pharmaceuticals LP | 6 | $340 |
| ABBVIE INC. | 27 | $314 |
| PFIZER INC. | 37 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $254 |
| Lundbeck LLC | 22 | $251 |
| Lilly USA, LLC | 11 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
Products named: Auvelity, AIRSUPRA, REXULTI, CAPLYTA, Ozempic, NURTEC ODT, QULIPTA, Wegovy.
Industry payments across IL — which companies pay providers there.
